Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Emedastine

Next Previous
X
Search
Drug Profile

Emedastine

Alternative Names: AL 03432A; CGP 42125; Daren; Emadine; Eurodastin; KB 2413; KG 2413; LY 188695; Remicut

Latest Information Update: 15 Apr 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Nippon Organon
  • Developer Alcon; Kolon Pharmaceuticals; Kowa; MSD KK; Saluc Pharma
  • Class Antiallergics; Antihistamines; Benzimidazoles; Small molecules
  • Mechanism of Action Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Allergic conjunctivitis; Allergic rhinitis; Atopic dermatitis; Dermatitis; Urticaria
  • Discontinued Allergic asthma; Perennial allergic rhinitis; Seasonal allergic rhinitis

Most Recent Events

  • 09 Apr 2019 Novartis completed the spin-off of Alcon
  • 26 Aug 2010 Alcon has been acquired by Novartis
  • 16 Oct 2006 Discontinued - Clinical-Phase-Unknown for Allergic asthma in Japan (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top